7

Fip Icon

Advancing Integrated Services

Advancing Integrated Services icon Arch
Icon 1

FIP Development Goal 7 Workforce Element 

Globally, we will have: 

A patient-centred and integrated health services foundation for workforce development, relevant to social determinants
of health and needs-based approaches to workforce development.

Mechanisms 

  • Systematic development of education and training activities based on local healthcare systems, their capacity and funding.
  • Evidence of systematic development policies and strategies for the strengthening and transforming pharmaceutical workforce education and the systematic training of trainers and educators.
  • Education providers must ensure, by the provision of evidence-based approaches, that lecturers, teachers and trainers are themselves appropriately trained for capability and competency.
  • Enable the pharmaceutical workforce and key stakeholders to promote health equity through actions related to social determinants of health.
Icon 1

FIP Development Goal 7 Practice Element 

Globally, we will have: 

A people-centred and integrated health care provision that is based on an interprofessional and cross- setting seamless continuum including pharmacist-delivered professional services.

Mechanisms 

  • Define clear processes and procedures for developing and delivering integrated, needs-based services in practice and across all health care settings.
  • Develop and implement systems for the design, delivery and evaluation of such services in primary, secondary, tertiary, and urgent and emergency care services.
  • Recognise that people-centred integrated quality health services are the foundation for optimal clinical, humanistic, economic and sustainable health care outcomes.
  • Clearly identify patient and population needs that support the development and delivery of pharmaceutical services that are relevant to health needs.
  • Ensure capacity to deliver interprofessional integrated services during humanitarian crises, disasters and emergency situations.
  • Ensure collaborative working with others within the pharmacy team and other health care providers especially through transitions of care and lifespan care.
  • Implement quality measures of all outcomes of health care, from an integrated, holistic perspective, which take into account the Person’s Journey.
Icon 1

FIP Development Goal 7 Science Element 

Globally, we will have: 

Scientific strategies to evaluate expanded professional pharmacy services and programmes, including translational and reverse-translational research.

Mechanisms 

  • Create evidence of team-based, interdisciplinary science.
  • Establish a forum to facilitate translational and reverse translational research, with the goal to expand pharmaceutical services and drive innovative research.
  • Foster collaboration between pharmaceutical scientists and pharmacists to evaluate advanced services and help document the value added to healthcare systems.
Workforce Reference Guide for FIP Development Goal 7 Thumbnail

Workforce Reference Guide for FIP Development Goal 7

Developed by the FIP Workforce Development Hub (WDH), the Workforce Reference Guide collates all information, evidence and expertise from FIP to support our members with measuring progress, evaluation, implementation and transformation processes.

Click here to access the full Workforce Reference Guide for FIP Development Goal 7
Online pharmacy operations and distribution of medicines: Global Survey Report - FIP Community Pharmacy Section (2021) Thumbnail

Online pharmacy operations and distribution of medicines: Global Survey Report - FIP Community Pharmacy Section (2021)

Read Publication
Community Pharmacy at a Glance 2021: Regulation, scope of practice, remuneration, and distribution of medicines through community pharmacy premises and other outlets (2021) Thumbnail

Community Pharmacy at a Glance 2021: Regulation, scope of practice, remuneration, and distribution of medicines through community pharmacy premises and other outlets (2021)

Read Publication
Community Pharmacy Global Report 2021: Regulation, scope of practice, remuneration, and distribution of medicines through community pharmacy premises and other outlets (2021) Thumbnail

Community Pharmacy Global Report 2021: Regulation, scope of practice, remuneration, and distribution of medicines through community pharmacy premises and other outlets (2021)

Read Publication
Pharmaceutical services in immunization: Contributions, experiences, and implementation in the Americas region - Technical document (2021) Thumbnail

Pharmaceutical services in immunization: Contributions, experiences, and implementation in the Americas region - Technical document (2021)

Read Publication
FIP Position Statement: Emerging technologies and pharmacy practice (2020) Thumbnail

FIP Position Statement: Emerging technologies and pharmacy practice (2020)

Read Publication
146th EXECUTIVE BOARD: Intervention on provisional agenda item 6. Primary health care (2020) Thumbnail

146th EXECUTIVE BOARD: Intervention on provisional agenda item 6. Primary health care (2020)

Read Publication
71st World Health Assembly: Intervention on provisional agenda item 11.1 - Draft thirteenth general programme of work, 2019–2023 (2018) Thumbnail

71st World Health Assembly: Intervention on provisional agenda item 11.1 - Draft thirteenth general programme of work, 2019–2023 (2018)

Read Publication
70th World Health Assembly: Intervention on provisional agenda item 15.1 - Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018 (2017) Thumbnail

70th World Health Assembly: Intervention on provisional agenda item 15.1 - Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018 (2017)

Read Publication
140th WHO Executive Board: Intervention on provisional agenda item 10.5 ─ Cancer prevention and control in the context of an integrated approach (2017) Thumbnail

140th WHO Executive Board: Intervention on provisional agenda item 10.5 ─ Cancer prevention and control in the context of an integrated approach (2017)

Read Publication
Pharmacist Ethics and Professional Autonomy: Imperatives for Keeping Pharmacy Aligned with the Public Interest (2014) Thumbnail

Pharmacist Ethics and Professional Autonomy: Imperatives for Keeping Pharmacy Aligned with the Public Interest (2014)

Read Publication
FIP Reference Paper Collaborative Practice (2009) Thumbnail

FIP Reference Paper Collaborative Practice (2009)

Read Publication

FIP “Setting goals for the decade ahead” | Episode 11 | FIP DG 7: Advancing integrated services

FIP “Setting goals for the decade ahead” | Episode 11 | FIP DG 7: Advancing integrated services Thumbnail
August 18, 2021

Episode 11 of the FIP Development Goals Digital Programme is focused on “advancing integrated services”. The goal visualizes a people-centred and integrated health care provision that is based on an interprofessional and cross-setting seamless continuum including pharmacist-delivered professional services. Through the lenses of pharmaceutical sciences, workforce, education, and practice, this event aims to advance the ideals of integrated service delivery in a way that benefits our patients and lead to improvement of health outcomes.

Event outcomes:
1. Describe and explain the components of FIP DG 7 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 7 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 7
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Watch video

Technology and new logistics – a disruption or a forced opportunity for community pharmacies

Technology and new logistics – a disruption or a forced opportunity for community pharmacies Thumbnail
October 11, 2021

New niche & digital actors as well as on-line pharmacies are entering the pharmacy market. Healthcare is becoming more and more digital, and the development is partly exponential, and partly driven by the consumers – as such there is a consumerism of healthcare. How will this affect the patients, the current pharmacy model & the healthcare systems?

Learning objectives:

  • Understand the changing landscape of healthcare and pharmacy
  • Identify how new actors use technology to transform pharmacy services
  • Understand how digital transformation and tools support new business models and services, as well as is shaping a new patient/consumer behaviour
  • Describe how FIPs PHC strategy and the DGs can be used to transform pharmacy practice
  • Define a strategy for transform pharmacy linked to the “new normal”
Watch video

"Just Culture" approach to community pharmacy practice regulation - An overview

July 13, 2021

Many jurisdictions around the world have implemented Apology Legislation and non-punitive medication error reporting requirements in order to create transparency, learning and prevention to enhance patient confidence and patient safety in the healthcare system and work towards creating a Just Culture or a Culture of Safety in health professionals and practice sites.   This webinar will present the value and the experiences of jurisdictions, which have enacted legislation and additional standards of care, for community pharmacy practice. Spread and scale of learning through international collaboration exemplified by the international medical regulatory authority will also be presented.

Learning Objectives:

1)      The importance sections of the FIP #4757 (Pharmacists Role in Medication without Harm) and Culture of Safety.

2)      The value of Apology Legislation on medication error resolution, transparency and patient confidence.

3)      The value of centralised medication error reporting in community pharmacy practice to enhance patient safety, quality assurance and prevent errors.

4)      The importance of international collaboration for the evolution to “Just Culture” and supportive legislation.

Watch video

Boas Práticas de Farmácia /Good Pharmacy Practice

Boas Práticas de Farmácia /Good Pharmacy Practice Thumbnail
June 30, 2021

Participantes

– Ema Paulino , Membro do Comité Executivo/ Secretária Profissional da FIP

– Eduardo Tavares, Presidente da Entidade Reguladora Independente da Saúde (ERIS)

– Artur Nhanengue, Diretor dos Serviços Farmacêuticos do Hospital Central de Maputo (HCM) Moderador Santos Nicolau, Bastonário da Ordem dos Farmacêuticos de Angola

Watch video

Pharmacy Practice Research Virtual Summer Meeting for PhD students, Postdoctoral fellows and supervisors

Pharmacy Practice Research Virtual Summer Meeting for PhD students, Postdoctoral fellows and supervisors Thumbnail
June 24, 2021

The FIP Pharmacy Practice Research SIG (PPR SIG) was created with the main scope of increasing pharmacy practice contributions to global health through the provision of greater access to the latest high-quality international pharmacy practice research. The PPR SIG also aims to cultivate an international forum for the dissemination of quality, international pharmacy practice research for all stakeholders and stimulate communication, discussion, networking, and collaboration between international pharmacy practice stakeholders.

Based on this objective, this PPR virtual summer meeting aims to increase the quality and quantity of pharmacy practice research by exchanging and disseminating information at an international level. New networks and collaborations will be established on major themes for experienced researchers and higher degree students.

Watch Video

Ready, set, go! The role of the pharmacist in doping control in sports

Ready, set, go! The role of the pharmacist in doping control in sports Thumbnail
July 30, 2020

Moderator: Kerstin Wagner

Panellists:

  • Daniel Sanabria
  • Mark Stuart
  • Helen Zhang.
Watch video

Our work